| MBRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MBRX shares outstanding history going back to 6/2/2016:
Also see: MBRX Market Cap History MBRX YTD Return |
MBRX Shares Outstanding History — Moleculin Biotech Share Count Over Time
As of 5/7/2026 Moleculin Biotech has 5.34 million MBRX shares outstanding. Investors often track the MBRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MBRX share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 6/2/2016.
| MBRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MBRX Historical Shares Outstanding: +101.90% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MBRX Stock Price Chart |
| About Moleculin Biotech Inc |
| Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. Co. has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. We show 45 historical shares outstanding datapoints in our coverage of MBRX's shares outstanding history. Understanding the changing numbers of MBRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MBRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MBRX by allowing them to research MBRX shares outstanding history as well as any other stock in our coverage universe. |
| MBRX Current Stock Quote |
Quotes delayed 20 minutes  Free MBRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MBRX Share Performance |
| Shares Outstanding Peers |
| Moleculin Biotech (MBRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MBVX Shares Outstanding History MCK Shares Outstanding History MCRB Shares Outstanding History MD Shares Outstanding History MDCO Shares Outstanding History MDGL Shares Outstanding History MDT Shares Outstanding History MDXG Shares Outstanding History ME Shares Outstanding History MEDP Shares Outstanding History More Healthcare companies » |
MBRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
